Cook v. Brewer ( 2011 )


Menu:
  •                  FOR PUBLICATION
    UNITED STATES COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    DANIEL WAYNE COOK,                    
    Plaintiff-Appellant,
    No. 11-15303
    v.
    JANICE K. BREWER; CHARLES L.                  D.C. No.
    2:10-cv-02454-RCB
    RYAN; ERNEST TRUJILLO; CARSON
    OPINION
    MCWILLIAMS; DOES 1-50,
    Defendants-Appellees.
    
    Appeal from the United States District Court
    for the District of Arizona
    Robert C. Broomfield, Senior District Judge, Presiding
    Argued and Submitted
    March 10, 2011—Portland, Oregon
    Filed March 16, 2011
    Before: Diarmuid F. O’Scannlain, Susan P. Graber, and
    Consuelo M. Callahan, Circuit Judges.
    Opinion by Judge Callahan
    3891
    COOK v. BREWER                     3893
    COUNSEL
    Jon M. Sands, Federal Public Defender, Dale A. Baich
    (argued), Robin C. Konrad, Golnoosh Farzaneh, Assistant
    Federal Public Defenders, Phoenix, Arizona, for the plaintiff-
    appellant.
    3894                        COOK v. BREWER
    Thomas C. Horne, Attorney General, Kent E. Cattani
    (argued), Chief Counsel, Capital Litigation Section, Phoenix,
    Arizona, for the defendants-appellees.
    OPINION
    CALLAHAN, Circuit Judge:
    Plaintiff Daniel Wayne Cook (“Cook”), an Arizona pris-
    oner scheduled for execution on April 5, 2011, filed this
    action for equitable, injunctive and declaratory relief under 
    42 U.S.C. § 1983
     (“§ 1983”) against Janice Brewer, Governor of
    Arizona, as well as Charles Ryan, Ernest Trujillo, and Carson
    McWilliams, who are Arizona Department of Corrections
    (“ADC”) officials (collectively, “Defendants”). The district
    court granted Defendants’ motion to dismiss for failure to
    state a claim upon which relief may be granted under Fed. R.
    Civ. P. 12(b)(6) (“Rule 12(b)(6)”). On appeal, Cook chal-
    lenges the district court’s decisions regarding two of his
    Eighth Amendment claims.1 First, he argues that Defendants’
    intent to use a foreign manufactured non-Food and Drug
    Administration (“FDA”) approved substance (which Defen-
    dants state is sodium thiopental) in his execution creates a
    substantial and unnecessary risk of unconstitutional pain. Sec-
    ond, Cook contends that the administration of this substance
    by medical professionals would constitute deliberate indiffer-
    ence to his right to be free from cruel and unusual punish-
    ment. We affirm.
    1
    Cook raised a third claim in his Complaint, that the State’s failure to
    provide him with notice and information regarding the sodium thiopental
    that will be used in his execution violates his Fourteenth Amendment
    rights, but he does not challenge the district court’s decision on that claim
    in this appeal.
    COOK v. BREWER                       3895
    I
    Cook is scheduled for execution on April 5, 2011, for his
    role in two 1987 murders in Lake Havasu City, Arizona. State
    v. Cook, 
    821 P.2d 731
    , 738 (Ariz. 1991). Cook and his room-
    mate tortured, sodomized and killed Carlos Cruz Ramos and
    Kevin Swaney. 
    Id. at 736-37
    . A jury thereafter convicted him
    of two counts of first-degree murder and the court sentenced
    him to death under Arizona Revised Statutes §§ 13-503 and
    13-703. Id. at 737-38.
    After the Arizona courts denied appellate and post-
    conviction relief, Cook filed a petition for writ of habeas cor-
    pus, which the district court denied and we thereafter
    affirmed. Cook v. Schriro, 
    538 F.3d 1000
     (9th Cir. 2008),
    cert. denied 
    129 S. Ct. 1033
     (2009). On November 10, 2010,
    after the State sought a warrant of execution, Cook filed this
    § 1983 action in which he raised several claims related to the
    State’s use of sodium thiopental, one of three drugs used as
    part of execution by lethal injection. The district court subse-
    quently granted Defendants’ Rule 12(b)(6) motion to dismiss
    for failure to state a claim upon which relief may be granted.
    Cook then timely filed this appeal.
    II
    We review de novo a district court’s order granting a
    motion to dismiss under Rule 12(b)(6). Shroyer v. New
    Cingular Wireless Servs., Inc., 
    622 F.3d 1035
    , 1041 (9th Cir.
    2010). A pleading must include a short and plain statement of
    the claim showing that the pleader is entitled to relief. Fed. R.
    Civ. P. 8(a)(2). “[T]he pleading standard Rule 8 announces
    does not require ‘detailed factual allegations,’ but it demands
    more than an unadorned, the-defendant-unlawfully-harmed-
    me accusation.” Ashcroft v. Iqbal, 
    129 S. Ct. 1937
    , 1949
    (2009) (quoting Bell Atl. Corp. v. Twombly, 
    550 U.S. 544
    ,
    555 (2007)). “[A] plaintiff’s obligation to provide the grounds
    of his entitle[ment] to relief requires more than labels and
    3896                        COOK v. BREWER
    conclusions, and a formulaic recitation of the elements of a
    cause of action will not do.” Twombly, 
    550 U.S. at 555
     (inter-
    nal quotation marks omitted).
    [1] “A Rule 12(b)(6) motion tests the legal sufficiency of
    a claim. A claim may be dismissed only if ‘it appears beyond
    doubt that the plaintiff can prove no set of facts in support of
    his claim which would entitle him to relief.’ ” Navarro v.
    Block, 
    250 F.3d 729
    , 732 (9th Cir. 2001) (quoting Conley v.
    Gibson, 
    355 U.S. 41
    , 45-46 (1957)). “To survive a motion to
    dismiss, a complaint must contain sufficient factual matter,
    accepted as true, to ‘state a claim to relief that is plausible on
    its face.’ ” Iqbal, 
    129 S. Ct. at 1949
     (quoting Twombly, 
    550 U.S. at 570
    ). “A claim has facial plausibility when the plain-
    tiff pleads factual content that allows the court to draw the
    reasonable inference that the defendant is liable for the mis-
    conduct alleged.” 
    Id.
    [2] For a capital prisoner to establish an Eighth Amend-
    ment claim for exposure to future harm of severe pain consti-
    tuting cruel and unusual punishment from an execution
    method, he is required to show that “the conditions presenting
    the risk must be ‘sure or very likely to cause serious illness
    and needless suffering,’ and give rise to ‘sufficiently immi-
    nent dangers.’ ” Baze v. Rees, 
    553 U.S. 35
    , 50 (2008) (Rob-
    erts, C.J., plurality opinion) (quoting Helling v. McKinney,
    
    509 U.S. 25
    , 33, 34-35 (1993).2 In Baze, the Court explained
    2
    Neither party disputes that the “sure or very likely” and “substantial
    risk of serious harm” standard articulated by the plurality opinion in Baze
    is the proper standard here. 
    553 U.S. at 50
    . Notably, in Dickens v. Brewer,
    
    631 F.3d 1139
     (9th Cir. 2011) we affirmed that, like every other circuit
    court to consider the issue, “the Baze plurality’s substantial risk standard
    is the controlling standard for assessing the constitutionality of an execu-
    tion protocol.” 
    Id. at 1144-46
    ; citing Brewer v. Landrigan, 
    131 S. Ct. 445
    (2010) (holding that an Arizona execution could proceed because there
    was no evidence that the drug was “ ‘sure or very likely to cause serious
    illness and needless suffering’ ” (quoting Baze, 
    553 U.S. at 50
    ) (emphasis
    omitted)); Raby v. Livingston, 
    600 F.3d 552
    , 557 (5th Cir. 2010); Nooner
    COOK v. BREWER                          3897
    that “to prevail on such a claim there must be a ‘substantial
    risk of serious harm,’ an ‘objectively intolerable risk of harm’
    that prevents prison officials from pleading that they were
    ‘subjectively blameless for purposes of the Eighth Amend-
    ment.’ ” 
    Id.
     (quoting Farmer v. Brennan, 
    511 U.S. 825
    , 842,
    846 & n.9 (1994)).
    III
    Because Cook committed his crimes before November 23,
    1992, he has the choice to be executed by either lethal injec-
    tion or lethal gas. See 
    Ariz. Rev. Stat. § 13-757
    (B). Cook has
    not yet chosen a method of execution, and if he does not make
    a choice, the ADC must use lethal injection to execute him.
    
    Id.
    Arizona’s protocol for execution by lethal injection
    requires the sequential administration of sodium thiopental,
    pancuronium bromide, and potassium chloride. Dickens, 
    631 F.3d at 1142
    .
    Sodium thiopental is a fast-acting barbiturate that
    anesthetizes the inmate and permits the other chemi-
    cals to be administered without causing pain.
    Pancuronium bromide is a paralytic neuromuscular
    blocking agent that causes complete paralyzation and
    suffocation. Potassium chloride induces cardiac
    arrest. It is uncontested on this record that, if an
    inmate is not properly anesthetized by the sodium
    thiopental at the start of the execution, he will expe-
    rience significant pain and suffering from the admin-
    v. Norris, 
    594 F.3d 592
    , 598-99 (8th Cir. 2010); Jackson v. Danberg, 
    594 F.3d 210
    , 219-22 (3d Cir. 2010); Cooey v. Strickland, 
    589 F.3d 210
    , 220
    (6th Cir. 2009); Clemons v. Crawford, 
    585 F.3d 1119
    , 1125-26 (8th Cir.
    2009); Harbison v. Little, 
    571 F.3d 531
    , 535 (6th Cir. 2009); Emmett v.
    Johnson, 
    532 F.3d 291
    , 298 (4th Cir. 2008).
    3898                    COOK v. BREWER
    istration of the pancuronium bromide and potassium
    chloride. If the sodium thiopental is administered
    properly, however, there is no risk of pain during the
    execution.
    
    Id.
    Underlying Cook’s claims is the fact that Arizona has
    obtained sodium thiopental from a foreign source, rather than
    from the United States. In his reply brief, Cook summarizes
    the five allegations raised in his Complaint, which he asserts
    we must take as true. First, he alleges that the ADC “lacks the
    appropriate safeguards to ensure the imported substance it
    obtained is not contaminated, is viable, and is actually sodium
    thiopental.” Second, “the substance was obtained in violation
    of federal law.” Third, “a foreign-manufactured drug was pro-
    duced in an environment such that the drug may not be effec-
    tive, and that the drug could be contaminated or
    compromised.” Fourth, “drugs from foreign countries do not
    have the same assurance of safety as drugs actually regulated
    by the FDA, due to the risk that counterfeit or unapproved
    drugs will be sent to consumers and also because without reg-
    ulation of repackaging, storage conditions, and many other
    factors, drugs delivered to the American public from foreign
    countries may be very different from FDA approved drugs
    with respect to formulation, potency, quality, and labeling”
    (quoting Iverson v. Pfizer, Inc. (In re Canadian Import Anti-
    trust Litig.), 
    470 F.3d 785
    , 789 (8th Cir. 2006) (internal cita-
    tions omitted)). Fifth, “this substance will cause Cook to
    suffer pain if the drug is contaminated, compromised, or sub-
    standard, which in turn will cause excruciating pain when the
    next two drugs are administered.”
    Cook contends that the district court erred in granting
    Defendants’ motion to dismiss for two reasons. First, he
    argues that the foreign manufactured non-FDA approved
    sodium thiopental may be “contaminated, compromised, or
    otherwise ineffective, such that it will not properly anesthetize
    COOK v. BREWER                        3899
    him” or “might not actually be sodium thiopental at all” and
    that “using an unapproved substance from an unknown manu-
    facturer in an execution gives rise to a substantial risk of
    unconstitutional pain” in violation of the Eighth Amendment.
    Second, Cook contends that the administration of “an unap-
    proved substance from an unknown manufacturer in an execu-
    tion by medical professionals constitutes deliberate
    indifference” to his right to be free from cruel and unusual
    punishment in violation of the Eighth Amendment.
    IV
    At issue for both of these claims is whether Cook has suffi-
    ciently satisfied, to survive a motion to dismiss, Rule 8(a)’s
    pleading requirements to state facially plausible claims that
    the drug the ADC has obtained is “sure or very likely to cause
    serious illness and needless suffering” in violation of his
    Eighth Amendment right to be free from cruel and unusual
    punishment. See Baze, 
    553 U.S. at 50
    ; see also Iqbal, 
    129 S. Ct. at 1949
     (pleading standard). We conclude that Cook’s
    allegations fail to meet this standard.
    While the pleading standard for Rule 8(a) is liberal, the
    “[f]actual allegations must be enough to raise a right to relief
    above the speculative level.” Twombly, 
    550 U.S. at 555
    . In
    Iqbal, the Court noted that “[t]o survive a motion to dismiss,
    a complaint must contain sufficient factual matter, accepted as
    true, to ‘state a claim to relief that is plausible on its face.’ ”
    Iqbal, 
    129 S. Ct. at 1949
     (quoting Twombly, 
    550 U.S. at 570
    ).
    [3] Cook’s allegations that foreign manufactured non-FDA
    approved drugs “may not be effective,” “could be contami-
    nated or compromised,” and “may be very different from
    FDA approved drugs with respect to formulation, potency,
    quality, and labeling” are all speculative and overly general-
    ized claims applicable to every drug produced outside the
    United States. Cook does not make any specific allegations
    about the manufacturing process, formulation, potency, qual-
    3900                        COOK v. BREWER
    ity, or labeling of the drug at issue here. Cook also fails to
    allege any facts to support his claim that the drug might not
    actually be sodium thiopental or that it could be contaminated,
    compromised, or otherwise substandard such that it may not
    effectively anesthetize him and cause him unconstitutional
    pain when the next two drugs are administered. 
    Id.
     Cook’s
    allegation that the ADC lacks appropriate safeguards to
    ensure the sodium thiopental it obtained “is not contaminated,
    is viable, and is actually sodium thiopental” is also conclusory
    and without any supporting factual allegations. Moreover,
    Cook’s assertion that “the substance was obtained in violation
    of federal law” is again speculative and Cook has not made
    a sufficient showing that the lack of FDA approval of the
    sodium thiopental at issue here makes it sufficiently likely
    that the sodium thiopental is either not what it purports to be,
    or is otherwise adulterated.3 Rather, Cook relies on his allega-
    tions that Arizona’s sodium thiopental is imported and not
    approved by the FDA. But Landrigan, 
    131 S. Ct. 445
    , advises
    that these facts are not sufficient to state a plausible Eighth
    Amendment claim. Like the instant case, Landrigan involved
    an Arizona death row inmate challenging Arizona’s use of
    imported, non-FDA-approved sodium thiopental. Reversing
    the Ninth Circuit, the Supreme Court held that the district
    court abused its discretion in granting Landrigan’s motion for
    a preliminary injunction to stay his execution.
    [4] Cook distinguishes Landrigan on the grounds that it
    involved a preliminary injunction, whereas the instant case
    involves a motion to dismiss. Thus, while Landrigan had to
    provide enough evidence to make success on his claim “like-
    ly,” Cook only needs to allege enough facts to make his claim
    “plausible.” Nevertheless, the Court in Landrigan found “no
    evidence in the record to suggest that the drug obtained from
    3
    We express no view as to whether the sodium thiopental was obtained
    in violation of federal law. The actual legality of importing this drug is not
    at issue here, we are only concerned with the constitutionality of its use
    on Mr. Cook.
    COOK v. BREWER                            3901
    a foreign source is unsafe.” 
    Id.
     This statement clearly implies
    that the facts that Arizona’s sodium thiopental is imported and
    non-FDA approved do not themselves constitute evidence of
    danger. Thus, in this case, Cook’s bare allegations that the
    sodium thiopental is imported and non-FDA approved, even
    taken as true, do not plausibly suggest that the drug is “sure
    or very likely to cause serious illness and needless suffering”
    or otherwise creates a “substantial risk of serious harm” in
    violation of Cook’s Eighth Amendment right to be free from
    cruel and unusual punishment sufficient to survive a motion
    to dismiss. Baze, 
    553 U.S. at 50
    ; see also Iqbal, 
    129 S. Ct. at 1949
    .
    [5] We also reject any claim Cook makes that the adminis-
    tration of the allegedly incorrect, diluted or adulterated drug
    would cause him excrutiating pain when the other two drugs
    are administered.4 We have recently upheld Arizona’s lethal
    injection protocol in Dickens, when we stated that “the proto-
    col’s safeguards are adequate under the Baze standard.” 
    631 F.3d at 1141
    . We noted the following facts about the adminis-
    tration of the sodium thiopental:
    After the sodium thiopental is administered, the
    [Members of the Medical Team (“MTMs”)] confirm
    that the inmate is unconscious by “sight and sound”
    using the camera and microphone, and an MTM
    enters the execution chamber to physically confirm
    unconsciousness. If the inmate is conscious, the
    Director of the [ADC] may order the [Special Opera-
    tions Team (“SOT”)] members to administer an
    additional dose of sodium thiopental, and the MTMs
    go through the same steps to verify unconsciousness.
    The SOT members cannot administer the
    4
    To the extent that Cook alleges that the process of administering a sub-
    stance that is not sodium thiopental, or is a diluted or adulterated version
    of sodium thiopental could itself potentially cause him unconstitutional
    pain, he offers no factual support to support such an assertion.
    3902                   COOK v. BREWER
    pancuronium bromide until the MTMs have con-
    firmed that the inmate is unconscious and at least
    three minutes have elapsed from the commencement
    of the administration of the sodium thiopental. The
    IV lines are flushed with heparin/saline between
    each injection, to ensure that they are clean and func-
    tioning properly.
    
    Id. at 1143
    .
    [6] Nothing in Cook’s Complaint suggests that, even if he
    were to receive a substance that was not sodium thiopental, or
    was diluted or adulterated and failed to properly anesthetize
    him, Arizona’s protocol would fail to identify the problem
    and halt the process to prevent the administration of the
    pancuronium bromide and potassium chloride. Cook’s reli-
    ance on speculative and conclusory allegations is insufficient
    to state a facially plausible claim that the sodium thiopental
    the ADC has obtained is “sure or very likely to cause serious
    illness and needless suffering” in violation of his Eighth
    Amendment right to be free from cruel and unusual punish-
    ment. See Baze, 
    553 U.S. at 50
    ; see also Iqbal, 
    129 S. Ct. at 1949
    . We therefore affirm the district court as to Cook’s first
    claim.
    [7] Cook’s second claim is dependant on the sufficiency of
    his first claim. Cook argues that the medical professionals
    who would administer the foreign-manufactured non-FDA
    approved substance would know that administering this drug
    involves substantial risks and that by administering the drug
    they would demonstrate deliberate indifference to his medical
    needs. However, because Cook fails to make a facially plausi-
    ble claim that the sodium thiopental at issue here is “sure or
    very likely to cause serious illness and needless suffering,” or
    otherwise creates a “substantial risk of serious harm” he can-
    not show that the medical officials administering the drug
    would be medically indifferent. 
    Id.
    COOK v. BREWER                      3903
    Because Cook has failed to demonstrate that the district
    court erred as to either of his claims, the judgment of the dis-
    trict court is
    AFFIRMED.